MARLBOROUGH, Mass.--(BUSINESS WIRE)-- Global women’s health leader Hologic, Inc. (Nasdaq: HOLX) today announced that its Affirm® Contrast Biopsy Software, which combines contrast-enhanced diagnostic ...
McLaren Port Huron has expanded its women’s health and breast cancer care capabilities with the introduction of an upright breast biopsy system. Usually, breast biopsies require patients to step up ...
Hologic (HOLX) announced that its Affirm Contrast Biopsy Software, which combines contrast-enhanced diagnostic capabilities with accurate lesion targeting to help streamline workflow and accelerate ...
GlobalData on MSN
Hologic pockets CE mark for contrast biopsy software
Hologic has obtained a CE mark in Europe for Affirm, its contrast biopsy software for use in contrast-enhanced mammography ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback